- Home
- UNIT vs NKTR Comparison
UNIT vs NKTR Comparison
Compare UNIT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNIT | NKTR |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2024 | 1996 |
Fundamental Metrics
Financial Performance| Metric | UNIT | NKTR |
|---|---|---|
| Price | $11.14 | $69.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $8.88 | ★ $146.67 |
| AVG Volume (30 Days) | ★ 2.5M | 876.2K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 660.94 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,234,500,000.00 | $307,711,000.00 |
| Revenue This Year | $65.59 | N/A |
| Revenue Next Year | $1.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 91.49 | 86.00 |
| 52 Week Low | $4.05 | $0.63 |
| 52 Week High | $12.39 | $109.00 |
Technical Indicators
Market Signals| Indicator | UNIT | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 53.29 | 33.29 |
| Support Level | $5.62 | $64.30 |
| Resistance Level | $12.28 | $76.67 |
| Average True Range (ATR) | 0.47 | 3.37 |
| MACD | -0.13 | -1.96 |
| Stochastic Oscillator | 33.15 | 16.72 |
Price Performance
Historical ComparisonAbout UNIT Uniti Group Inc.
Uniti is the product of the August 2025 merger of the firm with Windstream, its former primary customer. The combined firm owns a 240,000 route-mile fiber network that serves enterprise and residential customers. Selling high-capacity fiber circuits to enterprises generates about 20% of consolidated revenue. Uniti's residential networks reach about 4.5 million households, mostly in less-populated markets in the Southeast, but only about 1.9 million of these locations have been upgraded with fiber. Legacy copper-cable networks serve the remainder. Residential services account for about a third of total revenue. Small business and wholesale services provided within this residential service territory account for about 20% of revenue.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.